Ophirex, Inc.
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Broad-spectrum Rapid Antidote: Varespladib IV to Oral Trial for Snakebite (BRAVIO) (NCT05717062) | Ophirex, Inc. | 2023-05-30 |
| Broad-spectrum Rapid Antidote: Varespladib Oral for Snakebite (NCT04996264) | Ophirex, Inc. | 2021-08-15 |
| Study of Varespladib in Patients Hospitalized With Severe COVID-19 (NCT04969991) | Ophirex, Inc. | 2021-06-30 |
Track Ophirex, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.